Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.
Inorganic nanocrystals as contrast agents in MRI: synthesis, coating and introduction of multifunctionality.
复制标题
DOI:
10.1002/nbm.2909
复制
发表时间:
2013-07
影响因子:
2.9
通讯作者:
Mulder, Willem J. M.
中科院分区:
文献类型:
--
作者:
Cormode, David P.;Sanchez-Gaytan, Brenda L.;Mieszawska, Aneta J.;Fayad, Zahi A.;Mulder, Willem J. M.
关键词:
Inorganic nanocrystals have myriad applications in medicine, which includes their use as drug or gene delivery complexes, therapeutic hyperthermia agents, in diagnostic systems and as contrast agents in a wide range of medical imaging techniques. For MRI, nanocrystals can produce contrast themselves, of which iron oxides have been most extensively explored, or be given a coating that generates MR contrast, for example gold nanoparticles coated with gadolinium chelates. These MR-active nanocrystals can be used in imaging of the vasculature, liver and other organs, as well as molecular imaging, cell tracking and theranostics. Due to these exciting applications, synthesizing and rendering these nanocrystals water-soluble and biocompatible is therefore highly desirable. We will discuss aqueous phase and organic phase methods for synthesizing inorganic nanocrystals such as gold, iron oxides and quantum dots. The pros and cons of the various methods will be highlighted. We explore various methods for making nanocrystals biocompatible, i.e. directly synthesizing nanocrystals coated with biocompatible coatings, ligand substitution, amphiphile coating and embedding in carrier matrices that can be made biocompatible. Various examples will be highlighted and their applications explained. These examples signify that synthesizing biocompatible nanocrystals with controlled properties has been achieved by numerous research groups and can be applied for a wide range of applications. Therefore we expect to see reports of preclinical applications of ever more complex MRI-active nanoparticles and their wider exploitation, as well as in novel clinical settings.
登录
查看更多内容
影响因子:
10.8
作者:
Choi CL;Koski KJ;Sivasankar S;Alivisatos AP
通讯作者:
Alivisatos AP
影响因子:
10.8
作者:
Durr, Nicholas J.;Larson, Timothy;Ben-Yakar, Adela
通讯作者:
Ben-Yakar, Adela
影响因子:
4.7
作者:
Torres Martin de Rosales R;Tavaré R;Glaria A;Varma G;Protti A;Blower PJ
通讯作者:
Blower PJ
影响因子:
56.9
作者:
Dubertret, B;Skourides, P;Libchaber, A
通讯作者:
Libchaber, A
影响因子:
15
作者:
Chou, Shang-Wei;Shau, Yu-Hong;Chen, Chia-Chun
通讯作者:
Chen, Chia-Chun